vwf other roles than hemostasism.docente.unife.it/francesco.bernardi/basi... · 6 how does vwf...
TRANSCRIPT
11/4/16
1
VWF other roles than hemostasis
Len$ngPJ,CasariCetalJTH2012
Summary 1: VWF & hemostasis
GPIb collagen collagen αIIbβ3 FVIII
multimerization dimerization
propeptide
synthesis
Structure/function relationship & functions
20.000kDa
500KDa(dimers) (LMWM)
(HMWM)
11/4/16
2
VWF other roles than hemostasis
Len$ngPJ,CasariCetalJTH2012
Vascular abnormalities in patients with VWD or AVWS Ø Up to 20% of patients with VWD present with gastrointestinal
(GI) bleeding particularly common in absence of HMWMs
Ø GI bleeding has been linked to the presence of angiodysplasia (small vascular malformation of the gut)
Ø Angiodysplastic lesions are thought to develop due to dysregulated angiogenesis, leading to the production of fragile vessels prone to bleeding
Ø Vascular malformations outside the GI track have also been reported in patients with VWD
11/4/16
3
VWF and angiogenesis
StarkeRDetalBlood2011
Ø Inhibition of VWF expression in human umbilical vein EC (HUVEC) using siRNA resulted in increased proliferation, migration and in vitro angiogenesis
HUVEC ± VWF-siRNA ± VWF on matrigel (in absence of growth factors) Capillary network formation was observed and quantify measuring total tube length
VWF and angiogenesis
StarkeRDetalBlood2011
Ø In vivo, angiogenesis and vascular density were found to be increased in the VWF deficient mouse, (in several physiological and pathological models)
Blood vessels (anti-α-smooth muscle actin-Cy3) in ears from CTR or VWF-ko mice Ø the constitutive vascular
network in VWF-ko mice is increased
Ø These data suggest that VWF is involved in the control of vascular development.
11/4/16
4
How does VWF control angiogenesis?
RandiAM&LaffanMAJTH2016
Ø Extracellular pathway
Ø Intracellular pathway
How does VWF control angiogenesis? Extracellular pathway: • VWF binds integrin αVβ3 on EC
• Pharmacological inhibition of αVβ3 inhibits angiogenesis • Genetic deficiency of β3 enhances angiogenesis
• αVβ3 is associated with VEGFR-2 signaling • Lack of β3 > é VEGFR-2 signaling > immature and fragile blood vessels
(similar to angiodysplastic lesions) • Lack of VWF > é VEGFR-2 signaling in EC (+ proliferation and
migration) > suggesting that VWF may control angiogenesis by inhibiting VEGFR-2 signaling
• In vascular smooth muscle cells the interaction of VWF with αVβ3 has been shown to affect arterial maturation
11/4/16
5
How does VWF control angiogenesis? Extracellular pathway: • VWF binds integrin αVβ3 on EC
• Pharmacological inhibition of αVβ3 inhibits angiogenesis • Genetic deficiency of β3 enhances angiogenesis
• αVβ3 is associated with VEGFR-2 signaling • Lack of β3 > é VEGFR-2 signaling > immature and fragile blood vessels
(similar to angiodysplastic lesions) • Lack of VWF > é VEGFR-2 signaling in EC (+ proliferation and
migration) > suggesting that VWF may control angiogenesis by inhibiting VEGFR-2 signaling
• In vascular smooth muscle cells the interaction of VWF with αVβ3 has been shown to affect arterial maturation
How does VWF control angiogenesis? Intracellular pathway: • VWF is stored in WPBs, which also contain vasoactive
molecules such as Angiopoietin-2 (Ang-2) • Ang-2 can act to destabilize blood vessels • and synergize with VEGFR-2 to promote angiogenesis
• Inhibition of VWF expression > increases (synthesis and) release of Ang-2
• Whether Ang-2 has a role in the increased, disrupted
angiogenesis and in angiodysplasia, associated with lack of VWF, is not know.
11/4/16
6
How does VWF control angiogenesis? Intracellular pathway: • VWF is stored in WPBs, which also contain vasoactive
molecules such as Angiopoietin-2 (Ang-2) • Ang-2 can act to destabilize blood vessels • and synergize with VEGFR-2 to promote angiogenesis
• Inhibition of VWF expression > increases (synthesis and) release of Ang-2
• Whether Ang-2 has a role in the increased, disrupted
angiogenesis and in angiodysplasia, associated with lack of VWF, is not know.
Ø All these data suggest that VWF is required for physiological angiogenesis possibly acting at multiple stages of blood vessel development.
von Willebrand Disease (VWD)
Acquired von Willebrand Syndrome
(AVWS)
Ø One of the most frequent bleeding disorder in humans
Ø Caused by congenital decrease or dysfunction of VWF
Ø Due to dysfunction or degradation of VWF, often in association with myeloproliferative and malignant disorders, aortic valve stenosis or left ventricular assist devices
11/4/16
7
VWF Ø VWF is synthetized by EC and stored in Weibel-Palade bodies
(WPB)
Ø The formation WPB is dependent on the synthesis of VWF
Ø WPB also contain vasoactive molecules, which can bind to VWF >>> raising the possibility that VWF directs and regulates their action after release (with consequent effect on angiogenesis)
VWF other roles than hemostasis
Len$ngPJ,CasariCetalJTH2012
11/4/16
8
VWF & inflammation Ø Indirect link: VWF directs P-selectin to WPBs, which is
important for its regulated exposure on activated EC
• Deficiency of VWF provokes impaired P-selectin surface expression and subsequent defects in leukocyte recruitment in the early phases of inflammation
VWF & inflammation Ø Indirect link: VWF directs P-selectin to WPBs, which is
important for its regulated exposure on activated EC
• Deficiency of VWF provokes impaired P-selectin surface expression and subsequent defects in leukocyte recruitment in the early phases of inflammation
Ø VWF may actively participate in the inflammatory response
• VWF can function as an adhesive surface for leukocytes via interactions with P-selectin, GP ligand-1 and β2-integrins
• the immune cell receptor Siglec-5 has also been identified as a receptor for VWF *
• platelet-decorated VWF strings at the surface of EC efficiently recruit leukocytes, even under conditions of high shear stress *
• finally, VWF–platelet complexes are critical to optimal extravasation of leukocytes
11/4/16
9
PegonJ,CasariCetalHaematologica2012
HEK293 HEK293-Siglec-5
Monocyte+PMAnoVWF
Monocyte+PMA+VWF
DUOLINK
To visualize proteins that colocalize (<40 nm)
the immune cell receptor Siglec-5 has been identified as a receptor for VWF
hBp://www.sigmaaldrich.com
• TwoprimaryanMbodiesraisedindifferentspeciesrecognizethetargetanMgenoranMgensofinterest.Species-specificsecondaryanMbodies,calledPLAprobes,eachwithauniqueshortDNAstrandaBachedtoit,bindtotheprimaryanMbodies.WhenthePLAprobesareincloseproximity(<40nm),theDNAstrandscaninteractthroughasubsequentaddiMonoftwootherconnecMngDNAoligonucleoMdes.A^erjoiningofthetwoaddedoligonucleoMdesbyenzymaMcligaMon,theyareamplifiedviarollingcircleamplificaMonusingapolymerase.FollowingamplificaMontheamplicons(several-hundredfold)arevisualizedbyhybridizaMontolabeledcomplementaryoligonucleoMdeprobes.TheresulMnghighconcentraMonoffluorescentprobes
11/4/16
10
hBp://www.abnova.com/products/products_detail.asp?catalog_id=DP0031
Plateletsadheredtoendothelialcell-boundultra-largevonWillebrandfactorstringssupportleukocytetetheringandrollingunderhighshearstress
JournalofThrombosisandHaemostasisVolume3,Issue3,pages562-570,3FEB2005DOI:10.1111/j.1538-7836.2005.01122.xhBp://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2005.01122.x/full#f5
No ADAMTS13
BernardoAetalJTH2005
Ø platelet-decorated VWF strings at the surface of EC efficiently recruit leukocytes, even under conditions of high shear stress
No platelets
11/4/16
11
Plateletsadheredtoendothelialcell-boundultra-largevonWillebrandfactorstringssupportleukocytetetheringandrollingunderhighshearstress
JournalofThrombosisandHaemostasisVolume3,Issue3,pages562-570,3FEB2005DOI:10.1111/j.1538-7836.2005.01122.xhBp://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2005.01122.x/full#f6
with ADAMTS13
BernardoAetalJTH2005
Ø platelet-decorated VWF strings at the surface of EC efficiently recruit leukocytes, even under conditions of high shear stress
VWF & inflammation
Importantly: Ø our knowledge of the physiologic relevance of VWF in
inflammatory processes is primarily derived from animal studies using different models for inflammation (such as atherosclerosis, wound healing, experimental allergic encephalomyelitis, cytokine-induced meningitis, and stroke)
Ø In patients, this connection is less well established, which
is probably attributable to the multifactorial nature of these inflammatory conditions.
11/4/16
12
VWF & inflammation Ø how the contribution of VWF to the inflammatory process might be regulated?
• secretion of VWF from EC and/or platelets allows the protein to participate in a timely manner in the inflammatory response process
How can the proinflammatory activity of VWF be counteracted?
ADAMTS-13 deficiencly is associated with: • increased leukocyte rolling on
unstimulated veins • and increased leukocyte
adhesion in inflamed veins, but only when VWF is present in experimental models of atherosclerosis (in which lack of ADAMTS-13 exaggerates the VWF–platelet dependent inflammatory response by increasing leukocyte recruitment to lesion sites)
ChauhanAKetalJEM2008
11/4/16
13
stroke model: • ADAMTS-13 regulates VWF-
dependent inflammatory responses > ADAMTS-13 deficiency increases susceptibility to focal cerebral ischemia
How can the proinflammatory activity of VWF be counteracted?
BecauseofVWFproinflammatoryresponse
ZhaoBQetalBlood2009
stroke model: • ADAMTS-13 regulates VWF-
dependent inflammatory responses > ADAMTS-13 deficiency increases susceptibility to focal cerebral ischemia
• intravenous administration of recombinant ADAMTS-13 in wild-type mice markedly reduced infarction volume
How can the proinflammatory activity of VWF be counteracted?
BecauseofVWFproinflammatoryresponse
ZhaoBQetalBlood2009
11/4/16
14
stroke model: • ADAMTS-13 regulates VWF-
dependent inflammatory responses > ADAMTS-13 deficiency increases susceptibility to focal cerebral ischemia
• intravenous administration of recombinant ADAMTS-13 in wild-type mice markedly reduced infarction volume
How can the proinflammatory activity of VWF be counteracted?
BecauseofVWFproinflammatoryresponse
ZhaoBQetalBlood2009
These results suggest that proteolytic degradation of VWF by ADAMTS-13 downregulates the proinflammatory potential of VWF.
VWF other roles than hemostasis
Len$ngPJ,CasariCetalJTH2012